Fda Approval News

Pharmaceutical company Lupin has received USFDA approval for its Modafinil tablets, intended to treat excessive sleepiness in adults. The drug is bioequivalent

The use of GLP-1 drugs in US children under 12 has significantly increased, despite lacking FDA approval for this age group, amidst concerns that one in five ch

Zydus has received U.S. FDA approval for its generic scurvy injection, which will be manufactured at its Jarod plant near Vadodara and marketed in the US by Zyd

Zydus Lifesciences has received final USFDA approval for its generic ascorbic acid injection, intended for treating scurvy in specific patient populations. This

Moderna's mRNA flu shot, mRNA-1010 (mFLUSIVA), has received FDA approval for adults aged 50 and up, marking the first mRNA flu vaccine to be approved. The appro

The FDA has approved Moderna's mFlusiva, a new flu vaccine for adults aged 50 or older, which utilizes the same mRNA technology that was crucial in developing t

The U.S. FDA has approved Moderna's first mRNA flu shot, mFlusiva, for adults aged 50 to 64 with traditional approval and for those 65 and older with accelerate

Lupin Limited has launched its Sugammadex Injection in the United States after receiving approval from the US Food and Drug Administration. The company claims i

Gland Pharma has received USFDA approval for its generic version of sugammadex injection, a drug used to reverse muscle relaxant effects during surgery. The app

Alembic Pharmaceuticals has received final USFDA approval for its generic prucalopride tablets, indicated for chronic idiopathic constipation, which are therape

Alembic Pharma has received approval from the U.S. FDA for its generic drug used to treat chronic constipation.

Cipla has received U.S. FDA approval for a generic version of an asthma and COPD drug, marking its first dry powder inhaler approval from its U.S.-based manufac

The US FDA has approved the world's first oral PCSK9 inhibitor, a new cholesterol-lowering pill offering a convenient alternative to injections for adults with

Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for generic Olaparib tablets, a cancer drug with an estimated US market size of

Drugmaker Merck announced that its new daily pill, Lipfendra, has received FDA approval for treating high LDL cholesterol. Lipfendra, a PCSK9 inhibitor, can be